Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 601–624 of 971 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control (standard practice) Clear all

Conditions: Pancreatic Ductal Adenocarcinoma (PDAC), Borderline Resectable Pancreatic Cancer, Pancreatic Neoplasms
Interventions: Gemcitabine Delivered by Transarterial Microperfusion; Combination Product
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Liver Failure
Interventions: Thymoglobulin, Placebo; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 4
States / cities: Weston, Florida • Cincinnati, Ohio • Cleveland, Ohio + 1 more

Conditions: Hypercholesterolemia, Hypercholesterolemia, Familial, Hypercholesteremia in Children, Hyperlipidemia in Children
Interventions: Best Practice Alert, Health Maintenance Topic; Behavioral
Lead sponsor: Geisinger Clinic; Other
Eligibility: 9 Years to 11 Years
Enrollment: 13,340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Frostbite
Interventions: Standard of care plus Epoprostenol infusion for 8 hours (hrs) per day up to 5 days maximum, Standard of Care + Placebo (Normal Saline)infusion for 8 hours per day up to 5 days maximum; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Emotions
Interventions: U-PEACE Intervention, SAU; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 13 Years to 18 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Insomnia, Shift-Work Related Sleep Disturbance
Interventions: Cognitive Behavioral Therapy for Insomnia for Firefighters (CBT-I-F), Fitbit Inspire HR Wrist Worn Device (NCT04176926); Behavioral · Device
Lead sponsor: Pacific University; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Forest Grove, Oregon

Conditions: type1diabetes
Interventions: Libre 2, Device for SMBG and Libre Pro; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 4 Years to 26 Years
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Menopause, Left Ventricular Dysfunction
Interventions: Menopausal Hormone Therapy; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 45 Years to 60 Years · Female only
Enrollment: 50 participants
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Irritable Bowel Syndrome
Interventions: Standard Acupuncture/Moxibustion (fixed protocol), Individualized Acupuncture/Moxibustion, Sham/Placebo Acupuncture/Moxibustion; Other
Lead sponsor: New York University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 171 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Suspected Typical Alzheimer's Disease (AD), Suspected Atypical Alzheimer's Disease (AD)
Interventions: Face-to-face evaluation (FF), TeleNP evaluation; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 60 Years to 90 Years
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Cancer, VTE (Venous Thromboembolism)
Interventions: Apixaban 2.5 mg twice daily, Apixaban 5 mg once daily, No anticoagulation; Drug
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years and older
Enrollment: 996 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2035
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Major Depression
Interventions: Interpersonal Psychotherapy, Problem-Solving Therapy, Brief Supportive Psychotherapy; Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 90 Years
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Stress Disorders, Post-Traumatic, Drinking Heavy
Interventions: Trauma Expressive Writing, Stigma Expressive Writing, Control; Behavioral
Lead sponsor: Syracuse University; Other
Eligibility: 18 Years and older
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Hypoplastic Left Heart Syndrome, Total Anomalous Pulmonary Venous Return, Truncus Arteriosus, Pulmonary Atresia With Ventricular Septal Defect, Transposition of the Great Arteries, Double Outlet Right Ventricle, Subpulmonary VSD, Tetralogy of Fallot, Double Outlet Right Ventricle With Subaortic Ventricular Septal Defect and Pulmonary Stenosis, Cardiopulmonary Bypass
Interventions: Normoxia (with controlled re-oxygenation), Standard of care ventilation; Other
Lead sponsor: University of Michigan; Other
Eligibility: Up to 29 Days
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Information Seeking Behavior
Interventions: Not listed
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Anxiety, Parent-Child Relations, Literacy
Interventions: Reach Out and Read; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: Up to 14 Days
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Breast Cancer
Interventions: Patient-Assisted Compression (PAC), Technologist-Controlled (TC) Compression; Device
Lead sponsor: GE Healthcare; Industry
Eligibility: 40 Years and older · Female only
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Boca Raton, Florida

Conditions: Arthritis
Interventions: Live Music Therapy, Recorded Music Therapy, Control; Other
Lead sponsor: April Armstrong; Other
Eligibility: 18 Years and older
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Pregnancy
Interventions: Maternal Vaccine Education; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 121 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 4
States / cities: Atlanta, Georgia • Decatur, Georgia • Riverdale, Georgia

Conditions: Clostridium Difficile Infection
Interventions: FMT, Antimicrobials; Biological · Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Parenteral Nutrition Associated Liver Disease
Interventions: Lovaza (fish oil); Drug
Lead sponsor: University of Tennessee; Other
Eligibility: 1 Day to 1 Year
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Human Papillomavirus-Related Carcinoma
Interventions: Best Practice, Educational Intervention, Interview, Questionnaire Administration, Training and Education, Vaccination; Other · Behavioral · Procedure
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 1,900 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: University Park, Pennsylvania • Seattle, Washington

Conditions: HIV Infections, Stigma, Social
Interventions: Standard of care engagement practices, Peer Navigators Addressing INtersectional Stigma to Improve HIV Prevention Among Criminal-Justice Involved Women; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Degenerative Disc Disease
Interventions: Not listed
Lead sponsor: Orthofix Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 9
States / cities: South Bend, Indiana • Southfield, Michigan • Missoula, Montana + 5 more

Search by objective public record fields.

PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)

A Randomized Controlled Clinical Trial of Thymoglobulin® After Liver Transplantation

Evaluating the Efficacy of Pediatric Lipid Screening Alerts

Epoprostenol Plus Conventional Therapy in COld and Frostbite Injury (ECCO)

Unified Protocol for Preventing Emotional and Academic Challenges in Education (U-PEACE)

A Pilot Study of Cognitive Behavioral Therapy - Insomnia (CBT-I) Among Professional Firefighters

Diabetes in African Youth

Menopausal Hormone Therapy And Left Ventricular Function

Acupuncture/Moxibustion for Irritable Bowel Syndrome (IBS)

VIdeo Telehealth in ALzheimer's: NeuroPsychology (VITAL-NP)

DOAC - Dosing Options in AntiCoagulation Prophylaxis

Interpersonal Therapy for Depression in Breast Cancer

Project QueST 2023: Queer Survivors of Trauma

Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period

Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities

Reach Out and Read (ROR) in the Neonatal Intensive Care Unit (NICU) Study

Patient-Assisted Compression in 3D - Impact on Image Quality and Workflow

The Effect of Music Therapy Intervention on Pain and Anxiety in Adult Patients Undergoing Total Shoulder Arthroplasty

Vaccine Acceptance in Pregnant Minority Women

FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI

Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 Supplementation

Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial

HIV Prevention Peer Navigation for Justice Involved Women

Virtuos Bone Graft in Lumbar Fusion